The important role of angiotensin receptor blocker on treatment of chronic heart failure
Huang, J.
Zhonghua Xin Xue Guan Bing Za Zhi 34(9): 773-774
2006
ISSN/ISBN: 0253-3758 PMID: 17217679 Document Number: 603171
Document emailed within 1 workday
Related Documents
Tao, Z-wei.; Huang, Y-wei.; Xia, Q.; Xu, Q-wen. 2005: Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction Chinese Medical Journal 118(2): 146-154Iwata, A.; Miura, S.-i.; Nishikawa, H.; Kawamura, A.; Matsuo, Y.; Sako, H.; Kumagai, K.; Matsuo, K.; Saku, K. 2006: Significance of combined angiotensin Ii receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant Journal of Cardiology 47(1): 1-7
de la Fuente Cid, R.; Varela Román, A. 2007: Which is the role of the angiotensin II receptor blockers (ARBs) for the treatment of heart failure? Do we work based on evidence/recommendations or pharmaceutical industry pressure? Anales de Medicina Interna 24(12): 607-609
Beloborodova, A.V.; Morozova, T.E.; Shilov, E.M. 2010: An experience of the use of angiotensin Ii receptor blocker losartan in patients with metabolic syndrome and chronic kidney disease Kardiologiia 50(8): 32-36
Tarantini, L.; Cioffi, G.; Opasich, C.; Di Lenarda, A.; Pulignano, G.; Del Sindaco, D.; De Feo, S.; Stefenelli, C.; Russo, P.; Catania, G. 2004: Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 441-449
Aoyama, N. 2007: Effect of combination therapy with angiotensin Ii type i receptor and aldosterone receptor blockers in heart failure Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 145-149
Kolber-Postepska, B. 1992: Treatment of chronic congestive heart failure using angiotensin converting enzyme inhibitors Wiadomosci Lekarskie 45(23-24): 903-906
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Fruhwald, F.M.; Kickenweiz, E.; Zweiker, R.; Klein, W. 2001: Angiotensin i receptor blockers for heart failure Wiener Medizinische Wochenschrift 151(7-8): 157-159
Bonarjee, V.V.; Dickstein, K. 2000: Use of angiotensin Ii receptor blockaders in heart failure Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(7): 817-821
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Diskin, C.J.; Stokes, T.J.; Dansby, L.M.; Radcliff, L.; Carter, T.B. 2007: Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker? Journal of Nephrology 20(4): 410-416
Liu, X.; Hong, K. 2015: A novel therapy option for heart failure with dual angiotensin receptor and neprilysin inhibition Zhonghua Xin Xue Guan Bing Za Zhi 43(12): 1025-1027
Hofman-Bang, C.; Rydén, L.; Ponikowski, P. 1991: Mortality studies in heart failure. the role of ACE inhibitors becomes more important Lakartidningen 88(51-52): 4407-4409
Ivanenko, V.V.; Riazantseva, N.V.; Tarasov, D.L.; Lopatin, I.M. 2004: Effect of beta-Blocker Bisoprolol on Function of Hibernating Myocardium in Patients with Chronic Heart Failure of Ischemic Etiology Kardiologiia 44(7): 57-61
Katagiri, T.; Takei, M.; Sakurai, M.; Matsuyama, T.; Sakai, T. 2006: Antiinflammatory action of angiotensin receptor blocker Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 5): 506-511
Partanen, J. 2003: Angiotensin receptor blocker often a valuable alternative to ACE inhibitors Duodecim; Laaketieteellinen Aikakauskirja 119(13): 1193-1196
Javier Trujillo-Santos, A.; Poveda-Gómez, F.; García-Alegría, J. 2002: Angiotensin Ii receptor antagonists in cardiac failure treatment Medicina Clinica 118(9): 347-352
Packer, M. 1995: Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 92(6): 1379-1382